Schinke T et al. |
Molecular determinants of arterial calcification. |
1998 |
Ann. Med. |
pmid:9920355
|
Akatsu T et al. |
Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy. |
1998 |
Bone |
pmid:9855457
|
Murakami T et al. |
Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9837778
|
Yun TJ et al. |
OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. |
1998 |
J. Immunol. |
pmid:9834095
|
Vidal NO et al. |
Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: down-regulation by glucocorticoids. |
1998 |
J. Endocrinol. |
pmid:9795357
|
Horwood NJ et al. |
Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. |
1998 |
Endocrinology |
pmid:9794488
|
Hakeda Y et al. |
Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9790989
|
Hofbauer LC et al. |
Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9784422
|
Filvaroff E and Derynck R |
Bone remodelling: a signalling system for osteoclast regulation. |
1998 |
Curr. Biol. |
pmid:9768352
|
Takai H et al. |
Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. |
1998 |
J. Biol. Chem. |
pmid:9765225
|
Akatsu T et al. |
Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9753612
|
Hofbauer LC and Heufelder AE |
Osteoprotegerin and its cognate ligand: a new paradigm of osteoclastogenesis. |
1998 |
Eur. J. Endocrinol. |
pmid:9724069
|
Yamamoto M et al. |
Hypocalcemic effect of osteoclastogenesis inhibitory factor/osteoprotegerin in the thyroparathyroidectomized rat. |
1998 |
Endocrinology |
pmid:9724059
|
Mizuno A et al. |
Structure of the mouse osteoclastogenesis inhibitory factor (OCIF) gene and its expression in embryogenesis. |
1998 |
Gene |
pmid:9714833
|
Vidal ON et al. |
Osteoprotegerin mRNA is increased by interleukin-1 alpha in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9703989
|
Brändström H et al. |
Tumor necrosis factor-alpha and -beta upregulate the levels of osteoprotegerin mRNA in human osteosarcoma MG-63 cells. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9703945
|
Morinaga T et al. |
Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor. |
1998 |
Eur. J. Biochem. |
pmid:9688283
|
Kwon BS et al. |
TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption. |
1998 |
FASEB J. |
pmid:9657524
|
Tsuda E and Higashio K |
[Osteoclastogenesis inhibitory factor (OCIF)/OPG]. |
1998 |
Nippon Rinsho |
pmid:9648461
|
Mizuno A et al. |
Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9647741
|